Regeneron, listed on NASDAQ as REGN, is a prominent biotechnology company at the forefront of developing innovative medicines for patients facing various health challenges.
Utilizing the force of scientific advancements, Regeneron is dedicated to bringing new and effective treatments to individuals in need, showcasing a commitment to improving healthcare outcomes through cutting-edge research and development.
Generated from their website's infomation